Capsugel expands manufacturing capacity at three FDF plants
Capsugel’s DFS Unit has upgraded three FDF (finished dose form) manufacturing facilities in the US and Europe.
Capsugel’s DFS Unit has upgraded three FDF (finished dose form) manufacturing facilities in the US and Europe.
Hikma Pharmaceuticals has signed onto a joint venture with MIDROC Pharmaceuticals to establish a presence in the Ethiopian pharmaceutical market.
CMO PCI Synthesis recently completed its sixth US FDA inspection at its cGMP site in Newburyport, Massachusetts.
Catalent Pharma Solutions has been named as the supplier of delayed-release technology for an epilepsy treatment launched by Supernus Pharmaceuticals in the US this month.
Recipharm has received approval to manufacture and package the opioid drug Abstral for Kyowa Hakko Kirin in Japan.